Cingulate Analyst Price Targets - Benzinga

Cingulate Inc

CINGNASDAQ

Trade with Public

Trade with Public

$4.24

-0.32-7.02%

Últ. Act.: Nov 5, 4:02 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

Cingulate Analyst Price Targets - Benzinga

Cingulate Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cingulate (CING).

Price Target Range — 8 Quarters

Analyst Consensus — 6 Analysts

5Buy

1Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$21Upside to Avg. PT+401.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 24, 2026	Roth Capital	Boobalan Pachaiyappan	PT Cut	Buy	$10→$9
Aug 20, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$52→$44
Jun 8, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$55→$52
May 26, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$20
Apr 8, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$58→$55
Mar 23, 2026	Roth Capital	Boobalan Pachaiyappan	PT Cut	Buy	$16→$14
Dec 8, 2025	Ascendiant Capital	Edward Woo	PT Cut	Buy	$62→$58
Nov 19, 2025	Roth Capital	Boobalan Pachaiyappan	PT Cut	Buy	$17→$16
Oct 15, 2025	Roth Capital	Boobalan Pachaiyappan	PT Raise	Buy	$10→$17
Aug 22, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$61→$62
May 27, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$60→$61
May 19, 2025	Roth Capital	Boobalan Pachaiyappan	PT Cut	Buy	$12→$11
Apr 21, 2025	Ascendiant Capital	Edward Woo	PT Cut	Buy	$75→$60
Mar 6, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$20
Jan 30, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$8→$20
Jan 10, 2025	Roth MKM	Boobalan Pachaiyappan	Initiate	Buy	$12
Nov 20, 2024	Maxim Group	Naz Rahman	Upgrade	Hold→Buy	—
Jan 5, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$42→$96
Dec 22, 2023	Laidlaw & Co.	Yale Jen	Downgrade	Buy→Hold	—
Dec 19, 2023	Maxim Group	Naz Rahman	Downgrade	Buy→Hold	—

Analyst Ratings News

PRO
Roth Capital Reiterates Buy on Cingulate, Lowers Price Target to $9

Roth Capital analyst Boobalan Pachaiyappan reiterates Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $10 to $9.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $44

Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $52 to $44.

Benzinga Newsdesk

Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts change outlook on top names. B of A cuts CPB, UBS cuts AJG PT, B of A boosts ORCL PT, Needham raises APLD PT, Morgan Stanley raises AAPL PT, BTIG raises NRIX PT, GLJ Research raises CLF PT.

Avi Kapoor

Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday

Top analysts changed their views on top stocks. For all changes, upgrades and downgrades, see analyst ratings page.

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $52

Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $55 to $52.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Cingulate, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cingulate (NASDAQ:CING) with a Buy and maintains $20 price target.

Benzinga Newsdesk